Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB26FGQZ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,927
Award facts
- Contract value 100% obligated
- $31,927.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $31,927.35 by the Defense Logistics Agency (DLA) on October 29, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 30, 2025, and performance to be executed from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds significant responsibility for federal medical procurement through the DLA Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its competitive capability to meet defense healthcare requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used in weight management, reflects the company's role in supporting Defense Health Agency and other federal healthcare systems with pharmaceutical commodities essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB26FGQZ7?
SPE2DB26FGQZ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FGQZ7 worth?
The government has obligated $31,927 on SPE2DB26FGQZ7.
Is contract SPE2DB26FGQZ7 an order under another contract?
Yes. SPE2DB26FGQZ7 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB26FGQZ7 competed?
The extent of competition for SPE2DB26FGQZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award